Want to track KZR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kezar Life Sciences, Inc. (KZR) Statistics
Valuation metrics
Market Cap 53.86M
Enterprise value -11.02M
Trailing P/E (ttm) -1.18
Forward P/E -1.84
PEG ratio 0.05
Price/Sales (ttm) -
Price/Book (mrq) 0.82
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.28
Overview
Shares outstanding 7.33M
Float 5.16M
Shares short 151.6K
% Held by insiders 0.16%
% Held by institutions 0.61%
Average volume (10 days) 572.54K
Average volume (90 days) 236.31K
Price summary
52-Week low 3.53
52-Week high 7.55
Beta 0.43
50-Day moving average 1.95
200-Day moving average 5.48
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 30 Oct 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.67%
Return on equity -0.58%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -33.76M
EBITDA -51.37M
Net income to common (ttm) -56.03M
Diluted EPS (ttm) -6.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 71.88M
Total cash per share (mrq) 9.02
Total debt (mrq) 2.33M
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 24.46%
Book value per share (mrq) 8.88
Cash Flow
Cash flow statement -51.78M
Levered free cash flow (LFCF) -29.15M
